Literature DB >> 28803936

Inhibition of HUVEC tube formation via suppression of NFκB suggests an anti-angiogenic role for SLURP1 in the transparent cornea.

Sudha Swamynathan1, Chelsea L Loughner1, Shivalingappa K Swamynathan2.   

Abstract

Previously, we have reported that the Secreted Ly6/uPAR related protein-1 (SLURP1) serves an important immunomodulatory function in the ocular surface. Here, we examine the involvement of SLURP1 in regulating corneal angiogenic privilege. Slurp1 expression detected by QPCR, immunoblots and immunofluorescent stain, was significantly decreased in mouse corneas subjected to alkali burn-induced corneal neovascularization (CNV). Addition of exogenous SLURP1 (6XHis-tagged, E. coli expressed and partially purified using Ni-ion columns) significantly suppressed the tumor necrosis factor-α (TNF-α)-stimulated human umbilical cord vascular endothelial cell (HUVEC) tube formation. SLURP1 suppressed the HUVEC tube length, tube area and number of branch points, without affecting their viability and/or proliferation. Exogenous SLURP1 in HUVEC also suppressed the TNF-α-induced (i) interleukin-8 (IL-8) and TNF-α production, (ii) adhesion to different components of the extracellular matrix, (iii) migration, and (iv) nuclear localization of NFκB. Together, these results demonstrate that SLURP1 suppresses HUVEC tube formation by blocking nuclear translocation of NFκB, and suggest a potential role for SLURP1 in promoting corneal angiogenic privilege.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenic privilege; Corneal epithelium; HUVEC; Inflammation; NFκB; SLURP1

Mesh:

Substances:

Year:  2017        PMID: 28803936      PMCID: PMC5628148          DOI: 10.1016/j.exer.2017.08.007

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  61 in total

Review 1.  Inflammatory corneal neovascularization: etiopathogenesis.

Authors:  John L Clements; Reza Dana
Journal:  Semin Ophthalmol       Date:  2011 Jul-Sep       Impact factor: 1.975

2.  Proteomic analyses of corneal tissue subjected to alkali exposure.

Authors:  Toral Parikh; Natalie Eisner; Praseeda Venugopalan; Qin Yang; Byron L Lam; Sanjoy K Bhattacharya
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-01       Impact factor: 4.799

3.  Cytokine expression in the alkali-burned cornea.

Authors:  C Sotozono; J He; Y Matsumoto; M Kita; J Imanishi; S Kinoshita
Journal:  Curr Eye Res       Date:  1997-07       Impact factor: 2.424

Review 4.  Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease.

Authors:  Stefano Barabino; Yihe Chen; Sunil Chauhan; Reza Dana
Journal:  Prog Retin Eye Res       Date:  2012-03-08       Impact factor: 21.198

Review 5.  Characteristics of the human ocular surface epithelium.

Authors:  S Kinoshita; W Adachi; C Sotozono; K Nishida; N Yokoi; A J Quantock; K Okubo
Journal:  Prog Retin Eye Res       Date:  2001-09       Impact factor: 21.198

6.  A novel pro-lymphangiogenic function for Th17/IL-17.

Authors:  Sunil K Chauhan; Yiping Jin; Sunali Goyal; Hyun Soo Lee; Thomas A Fuchsluger; Hyung Keun Lee; Reza Dana
Journal:  Blood       Date:  2011-09-08       Impact factor: 22.113

7.  SLURP-1, an endogenous α7 nicotinic acetylcholine receptor allosteric ligand, is expressed in CD205(+) dendritic cells in human tonsils and potentiates lymphocytic cholinergic activity.

Authors:  Takeshi Fujii; Kazuhide Horiguchi; Hiroshi Sunaga; Yasuhiro Moriwaki; Hidemi Misawa; Tadashi Kasahara; Shoutaro Tsuji; Koichiro Kawashima
Journal:  J Neuroimmunol       Date:  2013-12-11       Impact factor: 3.478

8.  ARS Component B: structural characterization, tissue expression and regulation of the gene and protein (SLURP-1) associated with Mal de Meleda.

Authors:  Renato Mastrangeli; Silvia Donini; Christie A Kelton; Chaomei He; Alessandro Bressan; Ferdinando Milazzo; Veniero Ciolli; Francesco Borrelli; Fabrizio Martelli; Mauro Biffoni; Ottaviano Serlupi-Crescenzi; Serenella Serani; Emilia Micangeli; Nabil El Tayar; Rosa Vaccaro; Tindaro Renda; Romeo Lisciani; Mara Rossi; Ruben Papoian
Journal:  Eur J Dermatol       Date:  2003 Nov-Dec       Impact factor: 3.328

9.  A recurrent mutation in the ARS (component B) gene encoding SLURP-1 in Turkish families with mal de Meleda: evidence of a founder effect.

Authors:  Guofang Hu; Mehmet Yildirim; Vahide Baysal; Ozlem Yerebakan; Ertan Yilmaz; H Serhat Inaloz; Amalia Martinez-Mir; Angela M Christiano; Julide Tok Celebi
Journal:  J Invest Dermatol       Date:  2003-06       Impact factor: 8.551

10.  Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade.

Authors:  Tina Dietrich; Jasmine Onderka; Felix Bock; Friedrich E Kruse; Dörte Vossmeyer; Roland Stragies; Grit Zahn; Claus Cursiefen
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

View more
  7 in total

Review 1.  Conjunctival goblet cells: Ocular surface functions, disorders that affect them, and the potential for their regeneration.

Authors:  Shivalingappa K Swamynathan; Alan Wells
Journal:  Ocul Surf       Date:  2019-11-14       Impact factor: 5.033

2.  Secreted Ly-6/uPAR-related protein-1 (SLURP1) is a pro-differentiation factor that stalls G1-S transition during corneal epithelial cell cycle progression.

Authors:  Sudha Swamynathan; Gregory Campbell; Anil Tiwari; Shivalingappa K Swamynathan
Journal:  Ocul Surf       Date:  2021-12-16       Impact factor: 6.268

3.  The secreted Ly-6/uPAR related protein-1 (SLURP1) stabilizes epithelial cell junctions and suppresses TNF-α-induced cytokine production.

Authors:  Gregory Campbell; Sudha Swamynathan; Anil Tiwari; Shivalingappa K Swamynathan
Journal:  Biochem Biophys Res Commun       Date:  2019-08-03       Impact factor: 3.575

4.  The secreted Ly6/uPAR-related protein-1 suppresses neutrophil binding, chemotaxis, and transmigration through human umbilical vein endothelial cells.

Authors:  Sudha Swamynathan; Anil Tiwari; Chelsea L Loughner; John Gnalian; Nicholas Alexander; Vishal Jhanji; Shivalingappa K Swamynathan
Journal:  Sci Rep       Date:  2019-04-11       Impact factor: 4.379

5.  UPARANT is an effective antiangiogenic agent in a mouse model of rubeosis iridis.

Authors:  Filippo Locri; Massimo Dal Monte; Monica Aronsson; Maurizio Cammalleri; Mario De Rosa; Vincenzo Pavone; Anders Kvanta; Paola Bagnoli; Helder André
Journal:  J Mol Med (Berl)       Date:  2019-06-26       Impact factor: 4.599

6.  Gaining insight on mitigation of rubeosis iridis by UPARANT in a mouse model associated with proliferative retinopathy.

Authors:  Filippo Locri; Noemi A Pesce; Monica Aronsson; Maurizio Cammalleri; Mario De Rosa; Vincenzo Pavone; Paola Bagnoli; Anders Kvanta; Massimo Dal Monte; Helder André
Journal:  J Mol Med (Berl)       Date:  2020-09-17       Impact factor: 4.599

7.  Kinsenoside Ameliorates Oxidative Stress-Induced RPE Cell Apoptosis and Inhibits Angiogenesis via Erk/p38/NF-κB/VEGF Signaling.

Authors:  Xu Luo; Shengjie Gu; Yujiao Zhang; Jianhong Zhang
Journal:  Front Pharmacol       Date:  2018-03-20       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.